DHSS solicits applications for radiation countermeasure consortium
The funding opportunity announcement (FOA) released by HHS, in conjunction with the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), calls for the members of the Centers for Medical Countermeasures against Radiation Consortium (CMCRC). The consortium will consist of 5-7 research centers and four consortium cores as selected by the FOA.
The goal of the CMCRC will be to employ multidisciplinary research expertise and development capacity to develop new medical products for the treatment of radiation exposure from terrorist attacks or accidental exposure. The program will support applied research and studies, and current candidate products with treatment or mitigation potential may be moved into validating and licensing studies. Clinical trials, however, will not be supported.
The CMCRC is a contract and grant program funded by NIH and NIAD to develop countermeasures to acute radiation syndrome. To date, CMCRC has yielded leading therapeutic and mitigating candidates to combat radiation exposure, as well as diagnostic tools to measure the levels of that exposure.
The application due date for the FOA is October 3, 2014.